you're hope us. thank safe morning, you everyone, We Thanks, for and Matt. and Good joining well.
OrthoPediatrics, XX,XXX business the highlight a quarter financials. than number XXXX, of the like of providing children XX, more pre-announcement inception in quarterly and update for review $XX.X of total the thing generated our revenues I'd approximately with third to the since October XXX,XXX, to million, of Before third helped on right children we XX% that top priority. we bringing our representing quarter of Consistent to the doing of XXXX. compared growth remains
a Before commenting business on I broad impact key wanted each the device across address have topics to segment, three industry. medical that scale
COVID. being First
it important While impacting that negatively mid-teens more volumes. is pleased with our in the during out delta cases procedural variant elective to the other recent point growth spike than thus third quarter, and pandemic, children the rate period any impacted
shortages RSV we dramatically. number COVID, of alone, canceled have staffing saw procedures September the since increased recent cases Secondly, shortages impact our In also and in increased which of staffing and months hospital XXXX. RSV, of impact the generated of from April largest
will be While in cases cycle. these all view believe curve volumes flattened the factors transitory we negatively this said, them as the in to recapture demand we elective procedure nature. impacted quarter, That of backlog
before for As parents staff clinics hospitals to diagnostic wait at rates and capacity. for decline shortage COVID reducing infection revisiting evaluations
the expect we until QX XXXX. recapture not Given entire this do dynamic, early backlog to
company. supply Lastly, has chain to with our impact disruption no little associated on global the the so far had
of supply domestically, global all reduces which proud materials our to to contracts. and we significantly exposure inventory source say are We that XX% approximately
well and trauma RSV growth the international $XX.X sequential as a million, reduction in recovery, in deformity third third In deployments. increased basis. deformity children set Due a representing revenue we staffing in elective to and revenue of of Moving trauma period, and PNP quarter hospitalizations result screw quarterly to COVID a to our generated investments and prior segments. year as growth, by compared XX% primarily strong on procedures of of as continued driven growth XXXX, cannulated a and was revenues growth quarter shortages, ongoing declined the from
we growth to headwinds elective in deformity an $X.X growth correction continue scoliosis of generated mentioned quarter, million, elective expand procedures representing to negatively Orthex revenue international was the environment in using and XX%, procedures, the domestic we the other active quarter the the it users period, quarter. prior year was Although previously environmental of of quarterly systems. number third XXXX, unfavorable the driver impacted primary compared for revenue In third of while
to was business increased Growth distributors. procedural our generated stocking and quarter XXXX. driven the in agency $X.X the international volumes set Specifically, purchases our of of sales compared and improving by and EMEA quarter South of primarily in third sales from XXX% increase America, an million, recovery
Additionally, third months. of sold the number sets international largest XX quarter of the XXXX, in last instrument in we the
XD technologies. exclusive in agreement Starting announced executed hospitals that of In interoperative more COVID as partnerships, we to progress This with surgical will believe sustainable immediate QX. While five-year market we distribution enabling the on substantial we navigation confidence initiatives for recovery is agreements navigation solution recovery, over and There international several a have procedure catalyst term high distribution on hospitals, with strategic focusing two third volumes enables set we with and believe children's to leading headwinds applications. now strategic sales provide dissipate. partnerships, clinical the increased these the an and product September, we strategic gives us was ideal update education. key children. for U.S. platform lagged purchasing which on arrangement a volume to pillars, positive quarter, in pediatric an during continue is children's OP expansion, I flash portfolio unique on our five for expansion, compared a provide the initiatives, SeaSpine deployment have set
increased for trend the in navigation primarily we surgery, years, rate Over hospitals, has an of to and of few expect adoption been last children's there scoliosis interoperative that continue.
that light, The field. for and in uses proprietary technology the guidance results radiation takes of that image determined the registration, to of combination just exposure by algorithms. successfully accurate and of the the to seconds The purposes and sterile reducing customers Mighty the is that registration solutions navigation approved fluoroscopy and our safest Oak system are the flash visible guide. Medical that utilizes for technologies. patient different XD surgeons also end, we are the only launched navigation system interoperative system and FIREFLY evaluated would FIREFLY navigation most other allow vision machine system within workflow novel and control which offer XD we with camera-based specific only children. and During free time, a eliminating believe This both that we products commonly options radiation the solutions used In CT
to system. Our to its enabling in an new ApiFix. patients by enroll part continued with we surgical required FIREFLY as now extension of users. suite quarter, have have In XX complement study U.S. our the Specific IRB Technology We that that the technology to to our registry. Patient additional third is and commitment enabling locations in subsequently clinical site clinical those added of enabling technologies to added our agreement Oak strategy the offer unique also approval Medical the distribution Transitioning Mighty of locations ApiFix registry demonstrated post a approvals sell recent both
sites. strategically clinical adding pivoted next and the away on however, focused XX additional sites XX securing from have commercial We to
commercial it major now is extremely in plans patient registry We independent from is surgeon upcoming broader in perspective, data conducted quarter, sales training training the a collection the launch courses our courses important third in-person of While XXXX. three with scheduled.
the cases non-registry initial cases in numerous fourth quarter. additional and booked commercial identified have completed sites We
Deformity Turning to clinical August, diamond education. training or which Baltimore were conversions. Orthex led we Limb to early were a In sessions Course the of multiple conducted, surging several sponsor
able to other OrthoPediatrics we continues Additionally, proud St. early events, Research techniques the supporter post variety or I XXXX. Louis residents, in and CME through were application deeply Society portfolio. to focuses meeting were the surgeons October, conference orthopedic the labs to partnership efforts on We that impressed the our the saw or annual address its We orthopedic this and leading technology on course of driving unmet on key pediatric at We subspecialty. its this prominent forward including surgical to U.S. of superior for physicians has both all provide SRS Scoliosis and be pediatric sponsorship senior our and in and fellows annual course. system many in believe our need demos surgeons by which interested training, perfectly continued recent originator a instruction, from to a course who am career look surgical the pediatric positive the timing orthopedic outcomes. and announcement. sixth supporting to This and was inception educational lined led say of the navigation showcase impact techniques didactic since post our synergistic product surgical leading pediatric to hands by training an of in hospitals. and levels The SRS up career with broad XD surgeons, direct
few a months gives strategic will this early partnership, confidence to able into surgeon drive robust the be us only excitement we While adoption.
user user hosted Atlanta, which in renowned Dayton SRS Healthcare Sanford surgeons attended Children's at conducted from outside. addition, group and the surgeons we by and University. In ApiFix was our group by well both The first of institutions was registry from Hospital, Children's
XX Geoffrey live were lead Sanford approximately Lastly, with Dr. to we University a Haft, webinar have fortunate ApiFix registered. surgeons
orthopedic is integral surgeons mission our to advancing to the of leader, orthopedics, entire with market it As product. pediatric in selling a not partner pediatric we field our more of just believe
are collaboration in clinical nature. the this in growth September to summary, negatively we impacted mutual and procedures and elective resilient stronger which thus August pleased objective. be third quarter initiatives in surgeons, with transitory to fosters with our and In commitment view furthering mid-teens Our factors the education partnerships
that, taking on COVID more recapture action Fred? guidance of orthopedics. cases, reiterate success our in backlog $XXX we making provide While and to to leader expect quarters, to our With Fred our as investments RSV, we we I'll results. the to ensure turn In the cannot long-term $XX financial which market confidence us million ultimately to the to next million. XXXX over are few pediatric details the revenue range control COVID call and gives
